A link between allergic rhinitis otitis media with effusion  by Suzuki, Masashi & Mogi, Goro
Allergology International (1998) 47: 177-182
Review Article
A link between allergic rhinitis and otitis media
with effusion
Masashi Suzuki and Goro Mogi
Department of Otolaryngology, Oita Medical University, Oita, Japan
ABSTRACT
The role of allergy, particularly allergic rhinitis (AR), in
otitis media with effusion (OME) is discussed. Because
both OME and AR are common in young children,
these disorders are occasionally seen in the same
patient. Many clinical and experimental reports have
discounted the allergies as a cause of middle ear effu-
sion (MEE) because type I allergic reactions in the nose
cause eustachian tube dysfunction but do not induce
MEE, because the associated tubal dysfunction has a
short duration. It has been shown that allergy-induced
tubal dysfunction significantly disturbs the clearance of
MEE. Since clinical and experimental studies have
demonstrated the efficacy of allergy treatment in
patients or animals having both diseases, combination
treatment for allergy and OME in patients with both
diseases should be initiated.
Key words: allergic rhinitis, nasal allergy, otitis media
with effusion, pathogenesis, Type I allergy.
INTRODUCTION
The causes and pathogenesis of otitis media with effusion
(OME) are considered to be multifactorial, involving infec-
tion of the tubotympanum, eustachian tube dysfunction,
and allergy. Allergic rhinitis (AR) is a typical immuno-
globulin E (lgE)-mediated allergic disorder. The role of
allergy, particularly of IgE-mediated immune reactions, in
OME has been debated. Although many recent laboratory
and experimental studies have discounted an allergic
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reaction as a cause of OME, the continuity of the mucous
membrane between the nose and tympanic cavity via the
eustachian tube, suggests that the middle ear mucosa
may respond functionally as a sensitized tissue in patients
with respiratory allergy.
In this paper, we review the evidence of IgE-mediated
allergic reactions in the etiopathogenesis of OME in
order to examine the role of allergy in OME.
INCIDENCE OF ALLERGY IN OTITIS MEDIA
WITH EFFUSION
A number of studies have reported a high incidence of
allergy in patients with OME. Jordan reported that allergy
was associated with OME in 91 of 123 patients (74%).1
Leckstested 82 children with OME using skin scratch tests
with common environmental, inhalant, pollen, and mold
allergens and found a positive reaction in 72 (88%)
potients.? Draper found OME in 270 of 520 (52%) chil-
dren with allergic rhinitis.:' Since the discovery of IgE in
1966,4 more specific allergy tests have been developed.
Bernstein and Reisman, using an objective definition of
OME, examined 200 consecutive OME patients for evi-
dence of allergy.s They reported that 46 of the patients
(23%) were allergic. Hurst defined allergy using the
radioallergosorbent test (RAST), serum IgE levels, and skin
tests, and found that allergies were present in 97% of the
patients with non-acute OME.6 The results indicated that
allergy and OME were correlated clinically in 89% of
patients. Fig. 1 shows the incidence of OME in patients
with AR from different age groups who were examined at
our institution between 1982 and 1996. Diagnosis of
allergic rhinitis was made based on the clinical symptoms,
results of skin tests, eosinophils in nasal secretion, nasal
provocation tests, RAST, and serum IgE levels. Otitis
media with effusion was diagnosed by the presence of
effusion in the tympanic cavity as determined by paracen-
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Fig. 2 Ratios of complications of nasal allergy (NA) in otitis
media with effusion (OM E) and of OME in NA.
the middle ear mucosa. King studied 72 ears of 56 chil-
dren and found that seven of 39 ears containing mucous
secretion showed 5-10% eosinophils, while no child with
serous effusion had eosinophil intlltrotion." Ivstam repor-
ted smears from 33 case patients with secretory catarrh,
and 13 of these had very small numbers of eosinophils.?
Jordan reported 123 patients with MEE; 91 (74%) were
diagnosed as allergic based on the presence of eosine-
phi Is in nasal smears, positive skin tests, and response
to allergy therapy. 1 However, he also found that direct
smears of the effusion only showed occasional eosino-
phils, scattered leukocytes, and no bacteria. Other studies
also failed to find eosinophils in MEE.1O,11 Recent studies
by Lim and Birck12 Bernstein and Reismon.f and Spila and
Karma 13 found no significant numbers of eosinophils in
MEE or middle ear mucosa from patients with OME.
Thus, a number of investigators have discounted MEE as
an allergy-related fluid. More recently, however, Hurst?
and Hurst and Venge 14 examined eosinophil cationic pro-
tein (ECP) in MEE and middle ear mucosa from 89
patients with OME and found elevated ECP in 87.5% of
MEE samples. Hurst suggested that OME is a sign of
allergic inflammation in the middle ear.6
Since the discovery of IgE,4 many investigators have
studied total IgE and specific IgE antibodies in MEE,
comparing them with values in corresponding sera.
Although Phillips et 0/. reported increased total IgE and
IgE-bearing cells in all MEE samples (n = 26) collected
from patients with OME,15 suggesting that MEE is an
allergy-related fluid, a majority of studies found that
MEE did not contain total or antigen-specific IgE anti-
body concentrations exceeding those in matched serum
samples, thus excluding MEE as a product of allergic
reactions. 5, 16-21
There are few immunocompetent cells in the normal
middle ear mucoso.F Mast cells are the exception. There
are significant numbers of mast cells in the tympanic
orifice of the eustachian tube and in other parts of the
middle ear in rats and in adult, neonatal, and developing
guinea pigs. 23,24 The evidence suggests that the middle
ear acts as an allergic shock organ. Miglets induced
OME in monkeys passively sensitized (with human anti-
ragweed IgE antibodies) by daily delivery of ragweed
pollen to the middle ear mucosa via an eustachian tube
cotheter." Miglets found that the constituents of the
provoked MEE were consistent with an allergic origin.
However, a replicating study by Doyle et 0/. failed to dis-
cover any MEE, even though they confirmed that pollen
was present in the middle ear rnucosc.i" Doyle et 0/.
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Fig. 1 Numbers of patients with otitis media with effusion
(OME; .) among patients with allergic rhinitis (0). Patients were
managed in the Department of Otolaryngology, Oita Medical
University between 1982 and 1996.
Because eosinophil infiltration is a phenomenon charac-
teristic of allergic reactions, many investigators have
examined eosinophils in middle ear effusion (MEE) and in
EOSINOPHILS AND IGE IN MIDDLE EAR
EFFUSION AND MIDDLE EAR MUCOSA
tesis. Because OME and AR are both common among
children, we determined the ratios at which both occurred
in three age-matched groups (mean age, 6 years; range
6-8). As shown in Fig. 2, the ratio of AR complications in
222 children with OME was 42%, whereas that of OME in
259 children with AR was 36%.7 These ratios were signifi-
cantly higher than those seen in the control group. Thus,
findings of previous and recent studies indicate that the
frequency of allergy in young patients with OME is high.
reported that the histologic evidence of an allergic reac-
tion was localized to the area of pollen-mucosal contact.
Doyle et a/. also suggested that using a catheter may
injure the tubal lumen and cause tubal dysfunction and
infection that could lead to middle ear inflammation and
the production of effusion.26Because the eustachian tube
is usually closed, only opening primarily during swallow-
ing or yawning, and because it is the only potential
pathway for antigen access to the middle ear, inhalant
antigens do not enter the tympanic cavity eosily."
Tomonaga et 0/. developed an animal model of nasal
allergy in guinea pigs by passive sensitization with serum
from homologous animals containing an antigen-specific
IgE antibody (dinitrophenilated [DNP]-ascaris).27 They
then injected antigen (DNP-ovalbumin) directly into the
tympanic cavity of the passively sensitized guinea pigs.
Although they found allergic changes in the mucosa lining
the tympanic bulla, there was no macroscopic effusion.
Results of their study agreed with those of Doyle et 0/.26
Both authors discounted an allergic etiology of OME.
However, based on the results of investigations on ECP
in MEE and eosinophils in the middle ear mucosa, Hurst"
and Hurst and Venqe!" asserted that OME is a sign of aller-
gic inflammation in the middle ear, and is associated with
an increase in eosinophils and a concomitant release of
ECP into the effusion in individuals with allergy. Hurst
argued that suggestions that allergies cannot produce
MEE, because of the gatekeeper function of the eustachian
tube,26 ignore the current understanding of immune-
mediated disease as exemplified by asthma and otopv."
Hurst cited Denburg28 to explain why allergic inflam-
mation occurs in the tympanic cavity of allergic subjects,
even though allergens do not reach that region. In aller-
gic persons, a dynamic state exists between the structural
epithelial cells of the airway and the progenitors of
basophils, eosinophils, and mast cells. These progenitors
are primed by allergen challenge, circulate in increased
numbers in the blood of patients with various forms of
airway inflammation, and become programmed to react
to exogenous stimuli.i" Therefore, Hurst suggested that
the allergic patient is more prone to develop OME after
having developed acute otitis medic."
INTERFERENCE OF EUSTACHIAN TUBE FUNCTION
BY ALLERGIC REACTIONS IN THE NASAL MUCOSA
The nasal mucosa communicates anatomically with the
nasopharyngeal and tubal mucosae. Therefore, allergic
inflammation of the nasal mucosa may cause edema and
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elevated secretion by the eustachian tube mucosa, result-
ing in tubal obstruction and dysfunction. Crifo et 0/.
demonstrated that intranasal allergen challenge decreases
tubal patency or causes complete tubal obstruction in
patients with perennial AR.29 Ackerman et 0/. observed
eustachian tube obstruction after intranasal pollen insuf-
flations with different doses in patients with AR to ragweed
ortimothy grass.30They compared the dose responses and
duration of eustachian tube obstruction to the patients'
levels of serum-lgE antibodies against the causative pollen
and found that the induced tubal obstruction was depen-
dent on and related to serum-lgE antibody activity. Skoner
et 0/. conducted a similar study of patients with nasal aller-
gies to house dust mites and obtained similar results.?'
Osur et 0/. used the nine-step pressure-swallowing test
to evaluate eustachian tube obstruction in 15 children
with ragweed hay fever prior to, during, and after seas-
ona I exposure to ragweed pollen. 32 They reported that the
development of eustachian tube obstruction correlated with
ragweed skin test wheal size and daily patient symptom-
medication scores during pollen exposure. They suggested
that children with ragweed hay fever develop eustachian
tube dysfunction during natural pollen exposure, but that
eustachian tube obstruction increased by seasonal allergy
is not, by itself, sufficient to produce MEE, since only one
child in their study developed evidence of MEE. Taken
together, these findings suggest that inflammation of the
nasopharynx and tubal orifice is important in the develop-
ment of eustachian tube dysfunction. Although persistent
tubal obstruction induces MEE,33 the tubal dysfunction
caused by the allergic inflammatory process does not
cause OME.
Tomonaga et 0/. studied the eustachian tube histologi-
cally and functionally in passively sensitized guinea pigs
after nasal antigen provocotion." They found significant
allergic reactions, such as marked eosinophil infiltration,
mast cell infiltration, edema, and hypersecretion, in the
mucosa of the nose, nasopharynx, and eustachian tube,
even though the histologic changes were limited to the
area near the pharyngeal orifice. These changes were
noticeable within 1 h of the nasal antigen challenge.
Tubal function was evaluated by inflation and deflation
tests using tympanometry after the eardrum was perfo-
rated. Tomonaga et 0/. reported a significant increase in
the opening pressure of the tube at 30 and 60 min after
the antigen challenge, in comparison with values before
the antigen challenge. The tubal mucociliary activity was
also disturbed significantly upon nasal allergic ottocks.r
The results of their study indicate that the morphological
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Nasal global improvement ratings
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Fig. 3 Correlation of global improvement ratings (GIR)
between nasal and ear symptoms in a patient group treated for
both OME and AR. r = 0.43; P < 0.05.
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who received s-CMC only. Azelastine hydrochloride, an
anti-allergy medicine, was developed for the treatment of
AR, asthma, and atopic dermatitis.37 S-carboxymethyl cys-
teine has been shown to accelerate the clearance of MEE.38
As shown in Fig. 3, global improvement ratings (GIR) bet-
ween nasal and ear symptoms in group A were significantly
correlated. However, the correlation was not significant in
group B.
In order to confirm the efficacy of Al in OME associ-
ated with AR, we recently performed experiments in an
animal model. Allergic rhinitis and OME were induced in
the same guinea pigs simultaneously using the method
reported previouslv" A total of 51 guinea pigs passively
sensitized with guinea pig IgE antibodies against DNP-
ascaris, had immunocomplex injected into the tympanic
cavity. Otitis media with effusion developed within a few
days and subsided approximately 10 days after instillation
of the immunocomplex. Thirteen animals received no
treatment (group A), 13 were given 1 mg/kg of Al (group
B), and 13 were given 2 mg/kg of Al (group C). Azelas-
A total of 53 patients diagnosed with OME accompanied
by perennial AR were enrolled in a clinical study conducted
by Kawauchi et al.36 The patients were randomly allocated
into two groups: group A, consisting of 30 patients who
received azelastine hydrochloride (Al) and s-carboxymethyl
cysteine (s-CMC), and group B, consisting of 23 patients
and functional dysfunctions of the tube evoked by nasal
allergic reactions were transient, culminating in no MEE.
These studies suggest that type I allergic reactions of the
nose are not an etiologic factorfor OME.
In order to investigate the influence of nasal allergic
reactions on the clearance of MEE, Mogi et a/. gener-
ated an animal model of simultaneous AR and OME in
the guinea pigs by passive sensitization with IgE anti-
bodies (for AR), and inoculation of immunocomplexes
into the tympanic cavity (for OME).34 After inoculation
with the immunocomplexes, intranasal antigen chal-
lenges were performed. The disappearance of MEE
appeared to be delayed in animals with induced nasal
allergic reactions; however, MEE was not found in
ears that had not been inoculated with the immuno-
complexes. The results of this study indicate that IgE-
mediated allergic reactions in the nose, nasopharynx,
and eustachian tube are indicative of a chronic disease
state and do not cause OME. This finding is consistent
with the results of an epidemiological study by Pukander
and Karma of 753 infants with acute otitis media.35
They reported a significantly longer persistence of
MEE in infants with a history of allergy compared with
those in a nonallergic control group. Mogi et al. recom-
mended that allergy treatment be combined with OME
treatment in patients with both AR and OME.34
EFFECT OF ANTIALLERGIC DRUGS ON OTITIS
MEDIA WITH EFFUSION IN ASSOCIATION WITH
ALLERGIC RHINITIS
Group A
Group B
Group C
Group D 3/12 (25.0%)
Fig. 4 The presence of middle
ear effusion (MEE; ~) on the
eleventh day after immunocom-
plex instillation into the tympanic
cavity of guinea pigs. OME,
otitis media with effusion; AR,
allergic rhinitis; Al, azelastine
hydrochloride.
tine hydrochloride was administered by gastric intubation
from the 3rd to 10th day after immunocomplex injection.
As a control, the 12 remaining guinea pigs were given
saline drops nasally instead of ONP-ovalbumin and did
not receive AZ (group 0). All animals were killed on the
11th day after immunocomplex instillation into the tym-
panic cavity and the degree of MEE stagnation was deter-
mined. Fig. 4 shows the incidence of MEE in each group.
In group A, 92.3% of guinea pigs had MEE, while the inci-
dence of MEE was significantly lower (30.8%) in group C
animals, compared with that of both group A and B ani-
mals (69.2%). These findings suggest that administration
of AZ significantly accelerates the clearance of MEE.
In order to see whether AZ (2 mg/kg) inhibits MEE pro-
duction, 14 non-sensitized, normal guinea pigs were
randomly assigned to one of two groups (seven each,
groups E and F). Group E animals received 2 mg/kg of
AZ for 5 consecutive days before immunocomplex instil-
lation into the tympanic cavity and for the 3rd day after
instillation. Group F animals, in which OME was induced
by immunocomplex instillation, served as non-treatment
controls. Group E and F animals were killed on the 4th
day after immunocomplex instillation because the MEE
stagnation peaks on that day. All group E and F animals
were found to have MEE, which suggests that AZ does not
alleviate experimental OME.
Because allergy-induced tubal dysfunction disturbs the
clearance of MEE and because the control of nasal aller-
gic inflammation may improve the eustachian tube
dysfunction induced by allergic reaction, combined treat-
ment of allergy and OME in patients with both diseases
should be indicated.
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